Chemed Corporation (che)
CHE — Company Overview
Chemed Corporation (CHE) is a mid-cap company in the Healthcare sector, operating in Medical Care Facilities.
| Ticker | CHE |
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Exchange | NYQ |
| Market cap | $6.51B |
| Last price | $498.09 |
| Size category | Mid Cap |
CHE — Business Description
Chemed Corporation (CHE) operates in Medical Care Facilities within the broader Healthcare market. Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, doctors, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates through two segments: VITAS and Roto-Rooter segments. The company offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company also provides direct medical services to patients, as well as spiritual and emotional counseling to both patients and their families. Chemed Corporation was incorporated in 1970 and is he…
Official website: https://www.chemed.com.
CHE — Investment Thesis
The investment thesis for Chemed Corporation (CHE) rests on how Healthcare dynamics, profitability, and valuation interact at today's price.
- Revenue is expanding at roughly 8.8% year-over-year (public data).
- Trailing P/E of 25.08× sits in a moderate band relative to high-growth peers.
- Forward P/E (18.25×) is below trailing P/E — earnings may be expected to improve.
- Dividend yield near 0.6% adds an income component to total return.
- Equity market capitalization is approximately $6.51B.
See the free estimates and earnings pages for public targets and growth metrics. Ownership, live news, and deeper models remain in Vest Terminal.
CHE — Financial Health
Financial health for Chemed Corporation (CHE) is summarized from publicly reported profitability, leverage, and cash-flow metrics.
Profit margin near 10.6% leaves a narrower cushion versus higher-margin peers. Positive free cash flow of $307.86M supports balance-sheet flexibility.
| Trailing P/E | 25.08× |
| Forward P/E | 18.25× |
| Price / Sales | 2.51× |
| Price / Book | 7.81× |
| Gross margin | 33.1% |
| Operating margin | 13.2% |
| Profit margin | 10.6% |
| Return on equity | 27.1% |
| Debt / Equity | 35.49 |
| Free cash flow | $307.86M |
CHE — Growth Outlook
Growth outlook for Chemed Corporation (CHE) depends on demand trends in Medical Care Facilities and the company's ability to convert revenue into sustainable earnings.
- Revenue growth of 8.8% suggests steady but measured expansion.
- Earnings growth of 43.7% year-over-year supports improving profitability.
- Price is 10.6% below the 52-week high.
CHE — Competitive Position
Chemed Corporation (CHE) is evaluated against peers on scale, margin structure, and capital efficiency within Healthcare.
- Competes within Healthcare, specifically in Medical Care Facilities.
- Market capitalization of $6.51B places CHE among mid-cap peers.
- Gross margin of 33.1% should be benchmarked against direct competitors.
CHE — Strengths
Strengths for Chemed Corporation (CHE) inferred from public financial metrics:
- Revenue growth of 8.8% year-over-year.
- Earnings growth of 43.7% year-over-year.
- Return on equity near 27.1% — efficient use of shareholder capital.
- Positive free cash flow ($307.86M).
- Moderate leverage (debt/equity 35.49).
CHE — Weaknesses
Weaknesses and pressure points for Chemed Corporation (CHE) based on available data:
Insufficient public data to assess this factor.
CHE — Opportunities
- Sustained revenue growth (8.8%) could support multiple expansion if margins hold.
- Positive free cash flow enables reinvestment, debt reduction, or shareholder returns.
- Forward earnings multiple below trailing P/E — potential earnings acceleration ahead.
CHE — Risks
- Standard market, regulatory, competitive, and execution risks apply to all public equities.
CHE — Summary
Chemed Corporation (CHE) is a mid-cap Healthcare company focused on Medical Care Facilities, listed on NYQ. Last price $498.09 with market cap $6.51B. Trailing P/E 25.08×. Revenue grew 8.8% year-over-year per public data. Notable strengths include revenue growth of 8.8% year-over-year. Public estimates and earnings snapshots for Chemed Corporation are on this site; ownership, live news, and deeper models remain in Vest Terminal.
Start Free — open CHE in Vest Terminal
Access live data, filings, ownership, and analysis for Chemed Corporation.
Chemed Corporation FAQ
What does Chemed Corporation (CHE) do?
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, doctors, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates through two segments: VITAS an…
What is CHE's P/E ratio?
Chemed Corporation has a trailing P/E of 25.08× based on publicly available market data.
Does CHE pay a dividend?
Indicated dividend yield: 0.6%. Confirm ex-dates and payout history in Vest Terminal.
What sector is CHE in?
Chemed Corporation is classified in Healthcare (Medical Care Facilities) on NYQ.
What is CHE's market capitalization?
Approximate market cap: $6.51B.
What are the main risks for CHE?
Standard market, competitive, and execution risks apply; see the Risks section.
What are the strengths of CHE?
Potential positives include revenue growth of 8.8% year-over-year, earnings growth of 43.7% year-over-year.
Where can I get analyst estimates for CHE?
Public analyst price targets and consensus for Chemed Corporation are on the free /stocks/che/estimates page. Deeper estimate history and models are available in Vest Terminal.